Linked Life Data

20448468

Source:http://linkedlifedata.com/resource/pubmed/id/20448468

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-4-20
pubmed:databankReference
pubmed:abstractText
The rising incidence of pertussis amongst adults and adolescents in industrialized countries could be reduced by replacing tetanus and diphtheria (Td) boosters with reduced-antigen-content dT-acellular pertussis (dTpa)vaccines. Repeated administration of a dTpa-IPV (dTpa-inactivated poliomyelitis; BoostrixTM Polio, GlaxoSmithKline)booster to adolescents, 5 years after their previous dose was evaluated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1554-8619
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
554-61
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV).
pubmed:affiliation
Zentrum fur Kinder-und Jugendmedizin, Universitatsmedizin, Rheinland-Pfalz, Germany.
pubmed:publicationType
Journal Article, Multicenter Study, Clinical Trial, Phase IV